Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Susac syndrome (SS) is a rare disorder characterized by the triad of central nervous system (CNS) dysfunction, branch retinal artery occlusions (BRAOs) and sensorineural hearing loss (SNHL). It is presumably due to autoimmune-mediated occlusions of microvessels in the CNS, the retina, and the inner ear.
Biomarker and diagnostic research for Susac syndrome has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
1 clinical trial registered, 1 recruiting. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
165 publications have been identified in PubMed for Susac syndrome. Research spans Review / Meta-Analysis (29%), Case Report / Case Series (27%), and Epidemiology / Natural History (19%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 48 | 29% |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 11:11 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Susac syndrome
Patient case studies |
44 |
27% |
Disease patterns and progression | 31 | 19% |
Clinical study results | 15 | 9% |
Testing and diagnosis research | 9 | 5% |
Laboratory research | 8 | 5% |
Other research | 6 | 4% |
New treatment approaches | 4 | 2% |
Patrick L (2026). [PMID: 41631906](https://pubmed.ncbi.nlm.nih.gov/41631906/). *Continuum (Minneap Minn)*. [Review / Meta-Analysis]
Maretta M (2026). [PMID: 41758468](https://pubmed.ncbi.nlm.nih.gov/41758468/). *Neurol Neurochir Pol*. [Diagnostic / Biomarker]
Zhao P (2026). [PMID: 41628833](https://pubmed.ncbi.nlm.nih.gov/41628833/). *Cancer Lett*. [Epidemiology / Natural History]
Koo J (2026). [PMID: 41437821](https://pubmed.ncbi.nlm.nih.gov/41437821/). *Haematologica*. [Clinical Trial Publication]
Dang J (2026). [PMID: 41541779](https://pubmed.ncbi.nlm.nih.gov/41541779/). *Kidney Int Rep*. [Epidemiology / Natural History]
El-Geneidy M (2026). [PMID: 42232993](https://pubmed.ncbi.nlm.nih.gov/42232993/). *Front Ophthalmol (Lausanne)*. [Case Report / Case Series]
Zhang W (2026). [PMID: 41076089](https://pubmed.ncbi.nlm.nih.gov/41076089/). *J Hepatol*. [Case Report / Case Series]
AlHazzani A (2026). [PMID: 41843409](https://pubmed.ncbi.nlm.nih.gov/41843409/). *Ocul Immunol Inflamm*. [Case Report / Case Series]
Allemand A (2026). [PMID: 42130936](https://pubmed.ncbi.nlm.nih.gov/42130936/). *Eur J Case Rep Intern Med*. [Case Report / Case Series]
Shirley M (2026). [PMID: 42144536](https://pubmed.ncbi.nlm.nih.gov/42144536/). *Drugs*. [Gene Therapy / Novel Therapeutics]
AI-curated news mentioning Susac syndrome
Updated Aug 13, 2026
Recent research identifies endothelial cell proteins as potential biomarkers for Susac syndrome, which may enhance diagnostic accuracy and patient management. This discovery could lead to improved understanding and treatment of the disease.
A recent study highlights the successful reperfusion of retinal arteriolar occlusion in a pediatric patient with Susac syndrome following the initiation of immunosuppressive therapy. This finding contributes to the understanding of treatment responses in rare neurological conditions.